| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,137 |
4,388 |
$360K |
| 99307 |
|
3,254 |
2,854 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
179 |
160 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
103 |
69 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
283 |
144 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
121 |
105 |
$1K |
| 81003 |
|
437 |
381 |
$783.20 |
| 87428 |
|
15 |
12 |
$668.72 |
| 90686 |
|
27 |
27 |
$399.63 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
26 |
$105.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
263 |
227 |
$90.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
205 |
170 |
$80.20 |
| 3074F |
|
1,320 |
1,142 |
$0.00 |
| 3079F |
|
67 |
61 |
$0.00 |
| 1111F |
|
1,046 |
906 |
$0.00 |
| 3075F |
|
15 |
15 |
$0.00 |
| G0406 |
Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth |
32 |
31 |
$0.00 |
| 3078F |
|
1,265 |
1,093 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,038 |
1,643 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
208 |
203 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
45 |
43 |
$0.00 |
| 4040F |
|
13 |
12 |
$0.00 |
| 3077F |
|
53 |
48 |
$0.00 |